I agree that this site is using cookies. You can find further informations here.
X
Spira, Alexander
257  results:
Search for persons X
?
1

A phase Ib study evaluating the recommended phase II dose, ..:

Juric, Dejan ; Barve, Minal ; Vaishampayan, Ulka...
Cancer Medicine.  13 (2024)  5 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
2

Clinical outcomes of older and younger patients treated wit..:

Hamadani, Mehdi ; Spira, Alexander ; Zhou, Xiaolei...
Blood Advances.  8 (2023)  1 - p. 93-98 , 2023
Link: https://doi.org/10.1182/..
 
?
3

XMT-1660: A Phase 1b trial of a B7-H4 targeting antibody dr..:

Hamilton, Erika ; Spira, Alexander ; Adams, Sylvia...
Gynecologic Oncology.  176 (2023)  - p. S158 , 2023
Link: https://doi.org/10.1016/..
 
?
4

A plain language summary of the results from the group of p..:

Spira, Alexander ; Girard, Nicolas ; Krebs, Matthew...
Future Oncology.  19 (2023)  33 - p. 2213-2225 , 2023
Link: https://doi.org/10.2217/..
 
?
5

Amivantamab, an Epidermal Growth Factor Receptor (EGFR) and..:

Cho, Byoung Chul ; Simi, Allison ; Sabari, Joshua...
Clinical Lung Cancer.  24 (2023)  2 - p. 89-97 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Management of infusion-related reactions (IRRs) in patients..:

Park, Keunchil ; Sabari, Joshua K. ; Haura, Eric B....
Lung Cancer.  178 (2023)  - p. 166-171 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Phase 1 study of fianlimab, a human lymphocyte activation g..:

Hamid, Omid ; Lewis, Karl ; Weise, Amy...
SKIN The Journal of Cutaneous Medicine.  7 (2023)  2 - p. s179 , 2023
Link: https://doi.org/10.25251..
 
?
8

Phase 2, multicenter, open-label basket trial of nab-siroli..:

Lee, Elizabeth ; Rodon, Jordi ; Demeure, Michael...
Gynecologic Oncology.  176 (2023)  - p. S185 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Real-world treatment patterns and clinical outcomes for che..:

Amonkar, Mayur M. ; Chase, Monica ; Myer, Nicole M....
Cancer Treatment and Research Communications.  36 (2023)  - p. 100712 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Practical Guidance for the Management of Adverse Events in ..:

Zhang, Jun ; Johnson, Melissa ; Barve, Minal...
The Oncologist.  28 (2023)  4 - p. 287-296 , 2023
Link: https://doi.org/10.1093/..
 
?
11

Real-world outcomes in patients with KRAS G12C–mutated adva..:

Gray, Jhanelle E. ; Hsu, Hil ; Younan, Diana...
Lung Cancer.  181 (2023)  - p. 107260 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Real‐world outcomes among patients with EGFR‐mutated non‐sm..:

Apple, Jon ; Shenolikar, Rahul ; De Silva, Kevin..
Cancer Medicine.  12 (2023)  12 - p. 13415-13425 , 2023
Link: https://doi.org/10.1002/..
 
?
13

Pamiparib in combination with tislelizumab in patients with..:

Friedlander, Michael ; Mileshkin, Linda ; Lombard, Janine...
British Journal of Cancer.  129 (2023)  5 - p. 797-810 , 2023
Link: https://doi.org/10.1038/..
 
?
14

ABCL-316 Health-Related Quality of Life and Tolerability in..:

Spira, Alexander ; Zhou, Xiaolei ; Liao, Laura...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S371-S372 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Mobocertinib (TAK-788) in epidermal growth factor receptor ..:

Popat, Sanjay ; Ramalingam, Suresh ; Kim, Tae Min...
Lung Cancer.  165 (2022)  - p. S30-S31 , 2022
Link: https://doi.org/10.1016/..
 
1-15